Experimental mRNA vaccine for HIV shows promise in animals | Malay Mail

  • 📰 malaymail
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 86%

Malaysia Headlines News

Malaysia Latest News,Malaysia Headlines

WASHINGTON, Dec 10 — An experimental HIV vaccine based on mRNA — the same technology used in two highly successful Covid-19 vaccines — has shown promise in experiments in mice and monkeys, according to a study published Thursday in Nature Medicine. The research, which was carried out by...

WASHINGTON, Dec 10 — An experimental HIV vaccine based on mRNA — the same technology used in two highly successful Covid-19 vaccines — has shown promise in experiments in mice and monkeys, according to a study published Thursday inThe research, which was carried out by scientists at the National Institute of Allergy and Infectious Diseases , Moderna and other institutions, demonstrated that the vaccine was safe and prompted desired antibody and cellular immune responses against an HIV-like...

“This experimental mRNA vaccine combines several features that may overcome shortcomings of other experimental HIV vaccines and thus represents a promising approach.” Muscle cells in an inoculated animal build the two proteins, producing virus-like particles that are dotted with many copies of Env on their surface.

Co-author Paolo Lusso, also of NIAID, said these more “authentic” copies of the protein more closely mimicked natural infection than past efforts.The exact regimen differed among the animals, but involved priming the immune system with a vaccine optimised towards antibody creation, followed by boosters over the course of a year.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 1. in MY

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.